effect of the Individual and Family Self Management Program on medication adherence among school aged children with epilepsy

The effect of the Individual and Family Self-Management Program on medication adherence among school-aged children with epilepsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240314005

Enrollment

124

Registered

2024-03-14

Start date

2024-03-25

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The school-aged children with epilepsy being treated with oral anti-seizure medications. children with epilepsy, medication adherence, the Individual and Family Self-Management (IFSM) program

Interventions

The IFSM program will undergo a 12-week aimed at enhancing their understanding of epilepsy and medication behavior, as well as promoting self-management and medication adherence. These activities wil

Experimental Behavioral,No Intervention No treatment

The Individual and Family Self-Management (IFSM) program for school-aged children with epilepsy and their families,control group

Eligibility

Sex/Gender

All

Age

7 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: for children: 1) being treated with oral antiepileptic medications; 2) medication adherence less than 90% by pill count method during the past one month; 3) not having major developmental disorders such as cerebral palsy or autism spectrum disorder because these children typically cannot participate well in all sessions. Inclusion criteria for family: 1) Being the main care provider continuously for at least 1 month, 2) who live with children; 3) being able to communicate in Thai language; 4) have a smartphone that can connect to the internet at home and can access LINE and; 5) willingly to participate in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for Research Participants:1) Participants unable to continue in the study due to discomfort in sharing information will be excluded. 2) Those unable to participate in study activities until its conclusion or who opt to withdraw their consent will not be included.3) If children and families experience vision or hearing problems that impact their participation in the program for this study.

Design outcomes

Primary

Measure	Time frame
Medication adherence at pre-test, post-test, at 8 week, and at 12 week follow-up Pill count	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactChutimaporn Kangwal

Faculty of nursing, chulalongkorn University

ohmjung@hotmail.com0875187827

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026